Sobi and Biogen release interim results from the B-YOND study

Results from B-YOND study reinforce long-term clinical profile of Alprolix for the treatment of haemophilia B

Source: Pharmacy Europe - August 18, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Other conferences & symposia Haematology Latest News Source Type: news